newsfilter
← Latest News
PR Newswire·

Lunai Bioworks (Nasdaq: LNAI) Signs Definitive Collaboration Agreement with BrainStorm Therapeutics; Initial Parkinson's Disease Data Readout Targeted for First Half of 2027

Lunai Bioworks Inc. (Nasdaq: LNAI), a biology-first AI drug discovery company, today announced the execution of a Master Collaboration Agreement with ...